Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Biochemistry

Background:

• Nucleic acid analogs are crucial for developing new therapeutic and diagnostic tools.
• Oligonucleotide-based therapies require stable and efficient delivery systems.
• Existing phosphodiester backbones have limitations in stability and nuclease resistance.

Purpose of the Study:

• To develop an efficient synthesis of novel N3'-->P5' phosphoramidate nucleic acid analogs.
• To characterize the chemical and physical properties of these new analogs.
• To evaluate the duplex stability of these analogs with complementary nucleic acid strands.

Main Methods:

• Synthesis of 5'-O-DMT base-protected-3'-amino-2',3'-dideoxynucleosides.
• Solid-phase synthesis of oligonucleotide N3'-->P5' phosphoramidates using oxidative coupling.
• Characterization via HPLC, capillary electrophoresis, slab gel electrophoresis, and 31P NMR.
• Thermal denaturation studies (Tm) to assess duplex stability.

Main Results:

• Efficient synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates was achieved.
• These analogs formed remarkably stable duplexes with complementary RNA and DNA strands.
• Duplex melting temperatures exceeded those of parent phosphodiester compounds by 26-33°C.
• Characterization confirmed the structure and purity of the synthesized compounds.

Conclusions:

• Oligonucleotide N3'-->P5' phosphoramidates represent a promising class of nucleic acid analogs.
• Their enhanced duplex stability suggests significant potential for oligonucleotide-based diagnostics and therapeutics.
• The synthetic route provides a viable method for producing these novel compounds.